Clinical Trials for Hepatocellular Carcinoma (HCC)

Find clinical trials for hepatocellular carcinoma (hcc). Discover research opportunities and treatment options in your area.

74 Active Trials Found

Showing 74 trials on this page

Page 1 of 4

Same-day Radioembolization for Large HCC

NCT ID: NCT06944483

This clinical trial is studying a treatment called same-day radioembolization for patients with a type of liver cancer known as hepatocellular carcinoma (HCC). The trial aims to see if this treatme...

Recruiting

Type: observational Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of +3 more

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma

NCT ID: NCT06695026

This clinical trial is investigating a new treatment approach for patients with hepatocellular carcinoma (HCC), a type of liver cancer. The study is looking at a combination of three drugs: RZ-001,...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of +8 more

A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma

NCT ID: NCT07070076

This clinical trial is studying two different treatments for liver cancer called hepatocellular carcinoma (HCC) that might still be removable by surgery. The researchers want to find out if a treat...

Recruiting

Phase: NA Type: interventional Locations: Guangzhou, Guangdong, China

Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab

NCT ID: NCT07047586

This clinical trial is studying a new treatment approach for people with advanced liver cancer (called hepatocellular carcinoma or HCC) who have already tried certain immune-based therapies without...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)

NCT ID: NCT07059936

This clinical trial is studying how artificial intelligence (AI) and special imaging techniques can help predict how patients with liver cancer (specifically hepatocellular carcinoma) will respond ...

Recruiting

Type: observational Locations: Wuhan, Hubei, China

Multiparametric MRI for Characterization of Hepatocellular Carcinoma

NCT ID: NCT06999174

This clinical trial is exploring the use of a special type of imaging called multiparametric MRI to better understand and manage hepatocellular carcinoma (HCC), which is a type of liver cancer. The...

Recruiting

Type: observational Locations: Münster, , Germany

A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.

NCT ID: NCT07052253

This clinical trial is studying a new combination treatment for people with advanced liver cancer, specifically hepatocellular carcinoma (HCC). The study is testing two medicines, AK104/AK112 and T...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Wuhan, , China

A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE

NCT ID: NCT06040099

This clinical trial is studying a new treatment approach for patients with unresectable hepatocellular carcinoma (HCC), which is a type of liver cancer that cannot be surgically removed. The resear...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States, Buffalo, New York, United States +31 more

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

NCT ID: NCT06841172

This clinical trial is investigating the best way to treat patients with a type of liver cancer called hepatocellular carcinoma (HCC) who are experiencing limited disease progression, known as olig...

Recruiting

Phase: PHASE3 Type: interventional Locations: Jinan, Shandong, China

Streamlining Radioembolization for Small HCC

NCT ID: NCT06979219

This clinical trial is looking at a treatment called radioembolization for patients with a type of liver cancer known as hepatocellular carcinoma (HCC). The study aims to see if we can safely skip ...

Recruiting

Type: observational Locations: Seoul, , Korea, Republic Of, Goyang, , Korea, Republic Of +2 more

Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France

NCT ID: NCT07038863

This clinical trial is focused on helping the Mongolian community living in France by checking for three types of viral hepatitis infections—hepatitis B, hepatitis C, and hepatitis D. These infecti...

Not yet recruiting

Phase: NA Type: interventional Locations: Tours, , France, Lille, , France +9 more

Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.

NCT ID: NCT07027436

This clinical trial is studying a new treatment approach for people with a type of liver cancer called hepatocellular carcinoma (HCC) that can be removed with surgery. The trial is comparing two gr...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Hamilton, Ontario, Canada

Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria

NCT ID: NCT06773845

This clinical trial is exploring a treatment called ablative radioembolization for patients with a type of liver cancer known as hepatocellular carcinoma (HCC). Specifically, it focuses on patients...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of +2 more

FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma

NCT ID: NCT07012798

This clinical trial is studying a combination treatment for patients with a type of liver cancer called hepatocellular carcinoma (HCC) that is not easily treated with standard therapies. The treatm...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, Tianjin, China

PSMA PET for the Staging and Management of Hepatocellular Carcinoma

NCT ID: NCT07019844

This clinical trial is studying a new imaging technique called F18-Piflufolastat (PSMA) PET/CT to see how well it works for diagnosing and managing liver cancer known as hepatocellular carcinoma (H...

Recruiting

Type: observational Locations: Miami, Florida, United States

A Pilot Trial of Preoperative Irradiation With the STRIDE (Single Dose of Tremelimumab With Ongoing Durvalumab) Regimen (PRISM) for Resectable/Advanced Hepatocellular Carcinoma

NCT ID: NCT06994299

This clinical trial is exploring a new treatment approach for patients with a liver cancer called hepatocellular carcinoma (HCC) that can be removed through surgery. The study will combine two type...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States

Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk

NCT ID: NCT07010588

This clinical trial is studying different methods to detect early-stage liver cancer, specifically hepatocellular carcinoma (HCC), in patients who are at high risk for developing this condition. Th...

Not yet recruiting

Phase: NA Type: interventional Locations: Beijing, Beijing, China, Jinan, Shandong, China +10 more

Remote Symptom Monitoring on Patient-Reported Outcomes With Nudge Strategies Among Patients With Tumor in China

NCT ID: NCT06938945

This clinical trial is looking at how a digital tool can help patients with liver cancer, also known as hepatocellular carcinoma (HCC), manage their symptoms better. The researchers want to find ou...

Recruiting

Phase: NA Type: interventional Locations: Haidian, Beijing, China

On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer

NCT ID: NCT06877637

The BILLIONSTARS study is a research trial aimed at understanding how certain factors influence the response to treatment in patients with bile duct cancer (cholangiocarcinoma) and liver cancer (he...

Recruiting

Type: observational Locations: Kristianstad, , Sweden, Lund, , Sweden +1 more

Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma

NCT ID: NCT06741020

This clinical trial is exploring a new treatment approach for liver cancer, specifically hepatocellular carcinoma (HCC). Researchers are testing a method called hepatic artery infusion chemotherapy...

Recruiting

Phase: PHASE1 Type: interventional Locations: Hangzhou, Zhejiang, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions